Loading...
Market
What will be the market reaction to the Smiths Medical recall by end of 2024?
2
Resolution / Starting Odds
Stock price drop > 20% • 25%
Stock price drop ≤ 20% • 25%
No significant change • 25%
Stock price increase • 25%
Stock market data and financial news
Story
FDA Classifies Smiths Medical Tracheostomy Tubes Recall as Most Serious, 35 Injuries and 2 Deaths Reported
Sep 19, 2024, 05:40 PM
The U.S. Food and Drug Administration (FDA) has classified the recall of certain Bivona neonatal/pediatric and adult tracheostomy tubes made by Smiths Medical, a unit of ICU Medical, as the most serious type. This classification indicates that the defect could cause severe injury or death. The recall, which involves the removal of these tubes due to a manufacturing defect, has been linked to 35 reported injuries and two deaths. The FDA's action underscores the critical nature of the manufacturing defect in these medical devices.
View original story
Similar markets
Increase by 5% or more • 25%
No significant change • 25%
Decrease by up to 5% • 25%
Decrease by more than 5% • 25%
UnitedHealth Group stock rises • 25%
Cigna Group stock rises • 25%
CVS Health stock rises • 25%
All stocks fall • 25%
No change • 25%
Decrease by less than 10% • 25%
Decrease by 10-20% • 25%
Decrease by more than 20% • 25%
Positive reaction • 25%
Neutral reaction • 25%
Negative reaction • 25%
Mixed reaction • 25%
Increase by more than 5% • 25%
Increase by 0-5% • 25%
Decrease by 0-5% • 25%
Decrease by more than 5% • 25%
Acknowledge and propose further studies • 25%
Deny correlation and defend vaccine safety • 25%
Announce new vaccine formulations • 25%
No official response • 25%
Increase by more than 5% • 25%
Increase by up to 5% • 25%
Decrease by up to 5% • 25%
Decrease by more than 5% • 25%
Increase by 10% or more • 25%
Increase by less than 10% • 25%
No significant change • 25%
Decrease • 25%
Increase by more than 5% • 25%
Decrease by more than 5% • 25%
Fluctuate within 5% • 25%
No significant change • 25%
Increases by more than 5% • 25%
Increases by 0-5% • 25%
Decreases by 0-5% • 25%
Decreases by more than 5% • 25%
Increase in sales • 25%
No change in sales • 25%
Moderate decrease in sales • 25%
Significant decrease in sales • 25%
Increase by more than 5% • 25%
Increase by 0-5% • 25%
Decrease by 0-5% • 25%
Decrease by more than 5% • 25%